Cargando…

Antigen-Specific Immune Tolerance in Multiple Sclerosis—Promising Approaches and How to Bring Them to Patients

Antigen-specific tolerance induction aims at treating multiple sclerosis (MS) at the root of its pathogenesis and has the prospect of personalization. Several promising tolerization approaches using different technologies and modes of action have already advanced to clinical testing. The prerequisit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lutterotti, Andreas, Hayward-Koennecke, Helen, Sospedra, Mireia, Martin, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019937/ https://www.ncbi.nlm.nih.gov/pubmed/33828551 http://dx.doi.org/10.3389/fimmu.2021.640935

Ejemplares similares

Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis
por: Docampo, María José, et al.
Publicado: (2022)

Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions
por: Planas, Raquel, et al.
Publicado: (2018)

Characterization of Antigen-Induced CD4+ T-Cell Senescence in Multiple Sclerosis
por: Tomas-Ojer, Paula, et al.
Publicado: (2022)

T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis
por: Cruciani, Carolina, et al.
Publicado: (2021)

Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4(+) T Cells in Multiple Sclerosis
por: Faigle, Wolfgang, et al.
Publicado: (2019)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
por: Hofer, Livia Sophie, et al.
Publicado: (2020)

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life
por: Planas, Raquel, et al.
Publicado: (2014)

One toolkit to bring them all, and in silico analyze them
por: Li, Chennan, et al.
Publicado: (2023)

Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
por: Zhang, Qunfang, et al.
Publicado: (2018)

Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
por: Flórez-Grau, Georgina, et al.
Publicado: (2018)

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
por: Vlad, Benjamin, et al.
Publicado: (2023)

Synchronizing eye tracking and optical motion capture: How to bring them together
por: Burger, Birgitta, et al.
Publicado: (2018)

Neutrophil Extracellular Traps: How to Generate and Visualize Them
por: Brinkmann, Volker, et al.
Publicado: (2010)

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
por: Lünemann, Jan D., et al.
Publicado: (2008)

Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them?
por: Ramos-Leví, Ana M., et al.
Publicado: (2019)

A three-year longitudinal study of retinal function and structure in patients with multiple sclerosis
por: Hanson, James V. M., et al.
Publicado: (2021)

Bringing function to the forefront of cell therapy: how do we demonstrate potency?
por: Lowdell, Mark W., et al.
Publicado: (2023)

Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases
por: Riedhammer, Christine, et al.
Publicado: (2015)

Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins
por: Willis, Simon N., et al.
Publicado: (2015)

Brain Antigens Stimulate Proliferation of T Lymphocytes With a Pathogenic Phenotype in Multiple Sclerosis Patients
por: Gottlieb, Assaf, et al.
Publicado: (2022)

The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
por: Chunder, Rittika, et al.
Publicado: (2023)

Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis
por: Jelcic, Ivan, et al.
Publicado: (2018)

Bringing on the itch
por: Waizman, Daniel A, et al.
Publicado: (2019)

Adaptive Features of Natural Killer Cells in Multiple Sclerosis
por: Moreira, Antía, et al.
Publicado: (2019)

Editorial: Brain-Targeted Autoimmunity: Beyond Multiple Sclerosis
por: Nataf, Serge, et al.
Publicado: (2021)

Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
por: Safinia, Niloufar, et al.
Publicado: (2015)

Intestinal Uptake and Tolerance to Food Antigens
por: Xiong, Yuhong, et al.
Publicado: (2022)

Dual delivery of antigens shows promise
por: Luque-García, Jose L, et al.
Publicado: (2023)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
por: Wang, Jian, et al.
Publicado: (2020)

Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions
por: Planas, Raquel, et al.
Publicado: (2015)

Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS
por: Puthenparampil, Marco, et al.
Publicado: (2021)

The Choroid Plexus Is Permissive for a Preactivated Antigen-Experienced Memory B-Cell Subset in Multiple Sclerosis
por: Haas, Jürgen, et al.
Publicado: (2021)

Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis
por: Liu, Pen-Ju, et al.
Publicado: (2023)

Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out
por: Treiner, Emmanuel, et al.
Publicado: (2015)

Double and multiple stars, and how to observe them
por: Mullaney, James
Publicado: (2005)

Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
por: Marín-Prida, Javier, et al.
Publicado: (2022)

Regulatory T Cells Are Dispensable for Tolerance to RBC Antigens
por: Richards, Amanda L., et al.
Publicado: (2016)

Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance
por: Kishimoto, Takashi Kei, et al.
Publicado: (2018)

Nanoparticle Platforms for Antigen-Specific Immune Tolerance
por: Thorp, Edward B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1kel8dc24p75g7jml6u6q6dddt